These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8171543)

  • 21. Elevated fasting pro-insulin levels as a marker for impaired function after pancreas transplantation.
    Weide LG; Stratta RJ; Cushing K; Groggel G
    Transplant Proc; 1997; 29(1-2):678. PubMed ID: 9123477
    [No Abstract]   [Full Text] [Related]  

  • 22. Cyclosporine blood levels predict the likelihood of rejection and toxicity after simultaneous pancreas-kidney transplantation.
    Dawidson I; Ar'Rajab A; Lu C; Melone D
    Transplant Proc; 1995 Feb; 27(1):1324-6. PubMed ID: 7878901
    [No Abstract]   [Full Text] [Related]  

  • 23. An immunological comparison of pancreas transplants alone in nonuremic patients versus simultaneous pancreas/kidney transplants in uremic diabetic patients.
    Gruessner RW; Dunn DL; Tzardis PJ; Tomadze G; Adamec M; Moudry-Munns K; Sutherland DE
    Transplant Proc; 1990 Aug; 22(4):1581. PubMed ID: 2202123
    [No Abstract]   [Full Text] [Related]  

  • 24. Is induction therapy necessary for successful simultaneous pancreas and kidney transplantation in the cyclosporine era?
    Brayman KL; Egidi MF; Naji A; Friedman AL; Holland MT; Tomaszewski JE; Samini F; Perloff J; Grossman R; Barker CF
    Transplant Proc; 1994 Oct; 26(5):2525-7. PubMed ID: 7940776
    [No Abstract]   [Full Text] [Related]  

  • 25. The use of OKT3 in combined pancreas-kidney allotransplantation.
    Melzer JS; D'Alessandro AM; Kalayoglu M; Pirsch JD; Belzer FO; Sollinger HW
    Transplant Proc; 1990 Apr; 22(2):634-5. PubMed ID: 2183431
    [No Abstract]   [Full Text] [Related]  

  • 26. OKT3 first-line treatment of acute rejection episodes following combined pancreas and kidney transplantation.
    Cantarovich D; Hourmant M; Dantal J; Giral M; Paineau J; Karam G; Soulillou JP
    Transplant Proc; 1994 Apr; 26(2):549. PubMed ID: 8171548
    [No Abstract]   [Full Text] [Related]  

  • 27. Differential immunosuppressive strategies after combined pancreaticoduodenal and isolated kidney transplantation.
    Mellert J; Hopt UT; Büsing M; Hölzer H
    Transplant Proc; 1990 Aug; 22(4):1584-5. PubMed ID: 2389412
    [No Abstract]   [Full Text] [Related]  

  • 28. [Pancreas transplantation--between experiment and clinical method].
    Klempnauer J; Lück R; Hiller WF; Bektas H; Meier P; Pichlmayr R
    Internist (Berl); 1996 Mar; 37(3):289-94. PubMed ID: 8919946
    [No Abstract]   [Full Text] [Related]  

  • 29. Cyclosporine levels predict the likelihood of rejection after simultaneous pancreas/kidney transplantation.
    Dawidson I; Lu C; Ar'Rajab A; Rossi P; Melone D; Wheeler D
    Transplant Proc; 1994 Apr; 26(2):534. PubMed ID: 8171540
    [No Abstract]   [Full Text] [Related]  

  • 30. Combined pancreas transplantation increases morbidity of cadaveric renal transplantation.
    Rosen CB; Frohnert PP; Velosa JA; Engen DE; Sterioff S
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1613-4. PubMed ID: 1846479
    [No Abstract]   [Full Text] [Related]  

  • 31. Tacrolimus-based vs cyclosporine-based immunotherapy in combined kidney-pancreas transplantation.
    Ketel BL; Turton-Weeks S; Reed K; Barone GW
    Transplant Proc; 1996 Apr; 28(2):899. PubMed ID: 8623453
    [No Abstract]   [Full Text] [Related]  

  • 32. Specific humoral rejection of a pancreas allograft in a recipient of pancreas after kidney transplantation.
    Carbajal R; Karam G; Renaudin K; Maillet F; Cesbron A; Rostaing L; Cantarovich D; Soulillou JP; Blancho G
    Nephrol Dial Transplant; 2007 Mar; 22(3):942-4. PubMed ID: 17210592
    [No Abstract]   [Full Text] [Related]  

  • 33. Co-monitoring serum anodal trypsinogen, serum amylase, and serum creatinine accurately differentiates rejection from other causes of allograft dysfunction after simultaneous pancreas-kidney transplantation.
    Lieberman JM; Marks WH; Stuart FP; Abecassis MM; Florence LS; Kauffman D
    Transplant Proc; 1997; 29(1-2):676-7. PubMed ID: 9123476
    [No Abstract]   [Full Text] [Related]  

  • 34. Influence of rejection episodes on the relationship between exocrine and endocrine function in bladder-drained pancreas transplants.
    Brayman K; Morel P; Chau C; Stevens B; Goetz FC; Sutherland DE
    Transplant Proc; 1992 Jun; 24(3):921-3. PubMed ID: 1376533
    [No Abstract]   [Full Text] [Related]  

  • 35. [Pancreatic phospholipase A2].
    Ogawa M
    Rinsho Byori; 2001 Nov; Suppl 116():135-8. PubMed ID: 11797374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of the rejection markers tumor necrosis factor, ICAM-1, neopterin, interleukin-10, and soluble HLA in simultaneous pancreas and kidney transplantation with bladder drainage.
    Abendroth D; Storck M; Techt B; Zavazava N
    Transplant Proc; 1995 Dec; 27(6):3114-5. PubMed ID: 8539869
    [No Abstract]   [Full Text] [Related]  

  • 37. Exocrine pancreatic proteins in serum during pancreatic allograft rejection.
    Jönsson P; Källén R; Borgström A; Ohlsson K
    Pancreas; 1994 Mar; 9(2):244-8. PubMed ID: 7514792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Noninvasive diagnosis of acute rejection of solid organ transplants.
    Hartono C; Dadhania D; Suthanthiran M
    Front Biosci; 2004 Jan; 9():145-53. PubMed ID: 14766354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urine cytologic monitoring for rejection after vascularized pancreas transplantation.
    Radio SJ; Stratta RJ; Taylor RJ; Linder J
    Transplant Proc; 1992 Jun; 24(3):903-6. PubMed ID: 1604662
    [No Abstract]   [Full Text] [Related]  

  • 40. Pancreas transplantation.
    Sutherland DE
    Curr Opin Immunol; 1989 Aug; 1(6):1195-206. PubMed ID: 2679758
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.